QUESTLAB

Quest Laboratories Share Price

 

 

Start SIP in QUESTLAB

Start SIP

Performance

  • Low
  • ₹101
  • High
  • ₹103
  • 52 Week Low
  • ₹75
  • 52 Week High
  • ₹160
  • Open Price₹103
  • Previous Close₹103
  • Volume13,200
  • 50 DMA₹95.94
  • 100 DMA₹95.33
  • 200 DMA₹99.36

Investment Returns

  • Over 1 Month + 13.53%
  • Over 3 Month + 15.34%
  • Over 6 Month + 12.09%
  • Over 1 Year -24.56%

Smart Investing Starts Here Start SIP with Quest Laboratories for Steady Growth!

Invest Now

Quest Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 12.3
  • PEG Ratio
  • -
  • Market Cap Cr
  • 166
  • P/B Ratio
  • 1.8
  • Average True Range
  • 4.43
  • EPS
  • 8.63
  • Dividend Yield
  • 0
  • MACD Signal
  • 4.08
  • RSI
  • 54.09
  • MFI
  • 62.26

Quest Laboratories Financials

Quest Laboratories Technicals

EMA & SMA

Current Price
₹101.50
-1 (-0.98%)
pointer
  • Bearish Moving Average 5
  • Bullish Moving Average 11
  • 20 Day
  • ₹100.59
  • 50 Day
  • ₹95.94
  • 100 Day
  • ₹95.33
  • 200 Day
  • ₹99.36

Resistance and Support

101.67 Pivot Speed
  • R3 103.83
  • R2 103.17
  • R1 102.33
  • S1 100.83
  • S2 100.17
  • S3 99.33

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Quest Laboratories Ltd has an operating revenue of Rs. 152.72 Cr. on a trailing 12-month basis. An annual revenue growth of 31% is outstanding, Pre-tax margin of 18% is great, ROE of 16% is good. The company has a reasonable debt to equity of 2%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 10% and 5% from 50DMA and 200DMA. It is currently FORMING a base in its weekly chart and is trading around 19% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 83 which is a GOOD score indicating consistency in earnings, a RS Rating of 69 which is FAIR indicating the recent price performance, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 91 indicates it belongs to a poor industry group of Medical-Biomed/Biotech and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Quest Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-13 Quarterly Results & Others To consider other business matters.
2025-05-28 Audited Results
2025-01-27 Others To consider other business matters.
2024-11-14 Quarterly Results & Others To consider other business matters.

Quest Laboratories F&O

Quest Laboratories Shareholding Pattern

66.78%
0%
0.93%
25.5%
6.79%

About Quest Laboratories

  • NSE Symbol
  • QUESTLAB
  • BSE Symbol
  • Chairman & Managing Director
  • Mr. Anil Kumar Sabarwal
  • ISIN
  • INE0TNW01017

Similar Stocks to Quest Laboratories

Quest Laboratories FAQs

Quest Laboratories share price is ₹101 As on 12 January, 2026 | 08:02

The Market Cap of Quest Laboratories is ₹166.3 Cr As on 12 January, 2026 | 08:02

The P/E ratio of Quest Laboratories is 12.3 As on 12 January, 2026 | 08:02

The PB ratio of Quest Laboratories is 1.8 As on 12 January, 2026 | 08:02

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23